Real-time enrollment status for this adhd clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 3:26 AM UTC
| NCT Number | NCT06973577 |
| Recruiting Status | Active, Not Recruiting |
| Condition | ADHD |
| Phase | Clinical Trial |
| Target Enrollment | 308 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | April 7, 2026 (1 week ago) |
As of April 17, 2026: Clinical trial NCT06973577 is currently active_not_recruiting participants. This clinical trial study for adhd is not currently accepting new participants at 46 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06973577 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06973577 was last updated 1 week ago (April 7, 2026). HelloStudys verifies this status automatically.